YURAK-QON TOMIR TIZIMI EKSTRAGENITAL PATOLOGIYALARI BOʻLGAN HOMILADOR AYOLLARDA PREEKLAMPSIYA RIVOJLANISHINI ERTA PROGNOZLASH VA PROFILAKTIKA QILISHNING ZAMONAVIY KLINIK-BIOKIMYOVIY MEZONLARI
Keywords:
preeklampsiya, ekstragenital patologiya, yurak-qon tomir tizimi, endotelial disfunksiya, sFlt-1/PlGF nisbati, erta prognozlash, profilaktika.Abstract
Ushbu maqolada yurak-qon tomir tizimi (YQTT) ekstragenital patologiyalari boʻlgan homilador ayollarda preeklampsiya (PE) rivojlanishini erta prognozlash va profilaktika qilishning zamonaviy klinik-biokimyoviy mezonlari yoritilgan. YQTT kasalliklari fonida preeklampsiya kechishi ona va bola oʻlimi hamda perinatal asoratlar xavfini sezilarli darajada oshiradi. Tadqiqotda endotelial disfunksiya, angiogen disbalans (sFlt-1/PlGF nisbati) va metabolik oʻzgarishlarning diagnostik ahamiyati tahlil qilingan. Klinik-biokimyoviy monitoring yordamida patologiyani birinchi va ikkinchi trimestrda erta aniqlash hamda uning patogenetik profilaktikasi chora-tadbirlari asoslab berilgan.
References
Khan, K.S., Wojdyla, D., Say, L., Gülmezoglu, A.M., Van Look, P.F. WHO analysis of causes of maternal death: a systematic review. The Lancet, 2006. Vol. 367, pp. 1066-1074.
Magee, L.A., Pels, A., Helewa, M., Rey, E., von Dadelszen, P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension, 2014. Vol. 4(2), pp. 105-145.
Redman, C.W., Sargent, I.L. Latest advances in understanding preeclampsia. Science, 2005. Vol. 308(5728), pp. 1592-1594.
Cnossen, J.S., Morris, R.K., ter Riet, G., Mol, B.W., van der Post, J.A. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia. CMAJ, 2008. Vol. 178(6), pp. 701-711.
Powe, C.E., Levine, R.J., Karumanchi, S.A. Preeclampsia, a disease of the maternal endothelium. Circulation, 2011. Vol. 123(24), pp. 2856-2869.
Levine, R.J., Maynard, S.E., Qian, C., et al. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine, 2004. Vol. 350(7), pp. 672-683.
Zeisler, H., Llurba, E., Chantraine, F., et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. New England Journal of Medicine, 2016. Vol. 374(1), pp. 13-22.
Roberts, J.M., Cooper, D.W. Pathogenesis and genetics of pre-eclampsia. The Lancet, 2001. Vol. 357(9249), pp. 53-56.
Rolnik, D.L., Wright, D., Poon, L.C., et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. New England Journal of Medicine, 2017. Vol. 377(7), pp. 613-622.
Regitz-Zagrosek, V., Roos-Hesselink, J.W., Bauersachs, J., et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal, 2018. Vol. 39(34), pp. 3165-3224.
Duley, L., Gülmezoglu, A.M., Henderson-Smart, D.J., Chou, D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews, 2010. Iss. 11, pp. 1-45.
Brown, M.A., Magee, L.A., Kenny, L.C., et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension, 2018. Vol. 72(1), pp. 24-43.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo